Skip NavigationSkip to Content

Integrative molecular characterization of gallbladder cancer reveals microenvironment-associated subtypes

  1. Author:
    Nepal, Chirag
    Zhu, Bin
    O'Rourke, Colm J
    Bhatt, Deepak Kumar
    Lee, Donghyuk
    Song, Lei
    Wang, Difei
    Van Dyke, Alison
    Choo-Wosoba, Hyoyoung
    Liu, Zhiwei
    Hildesheim, Allan
    Goldstein, Alisa M
    Dean, Michael
    LaFuente-Barquero, Juan
    Lawrence,Scott
    Mutreja,Karun
    Olanich,Mary
    Bermejo, Justo Lorenzo
    Ferreccio, Catterina
    Roa, Juan Carlos
    Rashid, Asif
    Hsing, Ann W
    Gao, Yu-Tang
    Chanock, Stephen J
    Araya, Juan Carlos
    Andersen, Jesper B
    Koshiol, Jill
  2. Author Address

    Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Denmark., Division of Cancer Epidemiology and Genetics, NIH, USA., Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Institute of Medical Biometry and Informatics, Heidelberg University, Germany., Division of Cancer Epidemiology and Genetics, NIH, USA; The CGR Exome Studies Group, NIH, USA., Department of Public Health, School of Medicine, Pontificia Universidad Cat 243;lica de Chile, Santiago, 8330077 Chile and Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, 8380492 Chile., Department of Pathology, School of Medicine, Pontificia Universidad Cat 243;lica de Chile, Santiago, 8330024 Chile., Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stanford Cancer Institute and Stanford Prevention Research Center, Department of Medicine, Stanford School of Medicine, Stanford, California, USA., Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China., Hospital Dr. Hern 225;n Henr 237;quez Aravena, Temuco, 4780000 Chile; Department of Pathology, Faculty of Medicine, Universidad de La Frontera, Temuco, 4780000 Chile; Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, 8380492 Chile., Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: jesper.andersen@bric.ku.dk., Division of Cancer Epidemiology and Genetics, NIH, USA. Electronic address: koshiolj@mail.nih.gov.,
    1. Year: 2020
    2. Date: May
    3. Epub Date: 2020 12 01
  1. Journal: Journal of hepatology
    1. 74
    2. 5
    3. Pages: 1132-1144
  2. Type of Article: Article
  3. ISSN: 0168-8278
  1. Abstract:

    Background & aims: Gallbladder cancer (GBC) is the most common type of biliary tract cancer, but the molecular mechanisms involved in gallbladder carcinogenesis remain poorly understood. In this study, we applied integrative genomics approaches to characterize GBC and explore molecular subtypes associated with patient survival. Methods: We profiled the mutational landscape of GBC tumors (whole-exome sequencing on 92, targeted sequencing on 98, in total 190 patients). In a subset (n=45), we interrogated the matched transcriptomes, DNA methylomes and somatic copy number alterations. We explored molecular subtypes identified through clustering tumors by genes whose expression were associated with survival in 47 tumors and validated subtypes on 34 publicly available GBC cases. Results: Exome analysis revealed TP53 was the most mutated gene. The overall mutation rate was low (median 0.82 Mut/Mb). APOBEC-mediated mutational signatures were more common in tumors with higher mutational burden. Aflatoxin-related signatures tended to be highly clonal (present in =50% of cancer cells). Transcriptome-wide survival association analysis revealed a 95-gene signature that stratified all GBC patients into three subtypes that suggested an association with overall survival post-resection. The two poor-survival subtypes were associated with adverse clinicopathologic features (advanced stage, pN1, pM1), immunosuppressive microenvironments (myeloid-derived suppressor cell accumulation, extensive desmoplasia, hypoxia) and T cell dysfunction, while the good-survival subtype showed the opposite features. Conclusion: These data suggest that the tumor microenvironment and immune profiles could play an important role in gallbladder carcinogenesis and should be evaluated in future clinical studies, along with mutational profiles.

    See More

External Sources

  1. DOI: 10.1016/j.jhep.2020.11.033
  2. PMID: 33276026
  3. WOS: 000640696100016
  4. PII : S0168-8278(20)33820-4

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel